Skip to main content
Premium Trial:

Request an Annual Quote

Pierre Legrain, Thomas McNaughton, John Lewis, Hirday Bhathal, Aileen Alvarado-Swaisgood, Michael Courtney


Pierre Legrain left Hybrigenics on June 20 to head the department of biology at Commissariat à l’ Energie Atomique, the French Atomic Energy Commission, in Saclay, France. He was Hybrigenics’ chief technology officer. “It’s directly linked to the evolution of the company, since we are evolving from a platform technology company to a drug discovery company,” said Hybrigenics’ CEO Donny Strosberg.


Thomas McNaughton, formerly vice-president of legal affairs at Aclara Biosciences, has been appointed vice president of intellectual property at Hayward, Calif.-based Zyomyx. John Lewis, formerly vice-president of customer development at BD Biosciences Clontech, has become the company’s vice president of sales and marketing. McNaughton holds a BS in science and engineering from the US Military Academy at West Point and a JD from the University of Michigan. Lewis, who also previously worked as director of product sales for Celera Genomics, received his BS in zoology from the University of Florida. Meanwhile, Hirday Bhathal, vice president of corporate development, is leaving Zyomyx.


Aileen Alvarado-Swaisgood has become the Western regional sales manager of Nonlinear USA, a subsidiary of Newcastle upon Tyne, UK-based Nonlinear Dynamics. She will market proteomics software in the western US. Alvarado-Swaisgood spent the past ten years as a sales manager at Accelrys.


Michael Courtney has become chairman and CEO of Aptanomics of Lyon, France. Previously, he was COO of Noxxon Pharma; before that he was CSO of Transgene. Courtney holds a PhD from the University of London and a BS from the University of Glasgow.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.